 |
|
January 12, 2009 | |
CASE CCC IN THE NEWSHealth briefs Second Opinion Should Patients Be Told of Better Care Elsewhere? KUDOS...Drs. Nathan Berger and Joseph Nadeau have accepted an invitation to speak at the NCI-Mouse Models of Human Cancers Consortium (MMHCC) Steering Committee Business Meeting on January 12, 2009 in San Francisco, CA. Titles for the presentations are: KUDOS...Dr. Joseph Nadeau, was recently named as a Fellow by the American Association for the Advancement of Science (AACS) in the Section of Biological Sciences. Fellow are elected by their peers as recognition of meritorious efforts to advance science or its applications. All Fellows will be recognized for their contributions to science and technology at the Fellows Forum on February 14, 2009 during the AAAS Annual Meeting in Chicago. MARK YOUR CALENDARS- Farewell Party for Dr. Joanna BrellSave the date for an event to wish Dr. Joanna Brell all the best in her new role at the National Institutes of Health. A party in her honor is planned for January 23. A formal invitation will be issued with details this week. We give special thanks to Dr. Brell for her dedicated and capable service as Chair of the Case CCC Protocol Review and Monitoring Committee for the past year. In addition to that role, Dr. Brell has been an active faculty member in the Division of Hematology/Oncology for 7 years. She will be missed! CASE CCC SCIENTIFIC SERIES– HighlightsLast week's Case CCC Scientific Series kickoff was quite a success. Attended by over 60 researchers and graduate students, the first session highlighted the progress of three recipients of Cancer Center pilot funds for imaging projects. Drs. Susann Brady-Kalnay, Chris Flask, and Yanming Wang presented their research progress. Dr. Brady-Kalnay was congratulated for her successful R01 application resulting from her work. Discussions following each of the presentations were engaging and the presenters commented that these discussions will lead to new collaborations. To view photos of the event, please click here. The Scientific Series will continue its focus on the progress of the Cancer Center's recipients of pilot project funding, with another seminar scheduled for April 16. Announcements with details will be sent soon. FUNDING OPPORTUNITY– Ohio Cancer Research AssociatesThe Ohio Cancer Research Associates are accepting applications for research grant funding. Seed money grants awarded by Ohio Cancer Research Associates are made to support research activities broadly related to cancer and leukemia. The organization seeks to fund research that will lead to continued support at the national level. Full professors or their equivalent are not eligible. Only tenure track, junior faculty or equivalent scientific staffs are generally considered as appropriate. Postdoctoral fellows, research associates, research assistants, and graduate students are ineligible to apply as PIs, but they may be included as support staff. The PI must show evidence of independence; however, applicants must be within six years of their first independent research or faculty appointment. Well established investigators should not submit projects related to their current area of research. Investigators previously funded by Ohio Cancer Research Associates must provide justification that this application is significantly different from the previously funded project. Information regarding the results of the previously funded proposal and the PI's success in obtaining further national funding must also be provided. Deadline: February 20 For more information, please click here. FUNDING OPPORTUNITY– National Science Foundation Partnerships for International Research and Education (PIRE)The National Science Foundation (NSF) recently published its third biennial call of its flagship international initiative "Partnerships for International Research and Education" (PIRE). PIRE funds US universities to establish (or strengthen) international collaborations for research and education with world-leading overseas universities and research groups. The goal is principally to push forward frontier research and to help the US develop a globally literate and engaged scientific workforce. They suggest that you to look to UK universities for partners who have excellence in science, technology, innovation, and education. NSF is seeking to fund projects that meet all three of the following objectives: Deadline: February 26 For more information, please click here. MARK YOUR CALENDARS– Weekly Seminar Series on Applied Biostatistics in Clinical ResearchMark Schluchter, PhD will be teaching a weekly seminar series on Applied Biostatistics in Clinical Research, sponsored by W.T. Dahms Clinical Research Unit and the Cleveland Clinical and Translational Sciences Collaborative (CTSC). The seminars will run Mondays from 4:00 pm - 5:30 pm in School of Medicine E501, January 12– March 9. Online registration is open. To register and for more information, click here. For questions about the course, please contact Dr. Schluchter at mds11@case.edu. |
EVENTS**All events are open to anyone interested in attending January 12Hematology/Oncology Research In Progress Seminar cancelled Case CCC Basic Science Faculty Candidate Seminar January 13January 14Grand Rounds CSCRM Seminar January 15Taussig Cancer Center Core Curriculum Series Case CCC Basic Science Faculty Candidate Seminar TREC Seminar January 16Cancer Center Seminar Series/ Blood Club cancelled Hematology/ Oncology Fellows Seminar Taussig Cancer Institute Grand Rounds Cell Biology Pathology Research Seminar Series Case CCC Basic Science Faculty Candidate Chalk Talk more MARK YOUR CALENDARS:UPCOMING CANCER CENTER SYMPOSIUMSEmerging Trends in Cancer Immunotherapy Family-Centered Care Ohio Collaborative Conference on Bioinformatics (OCCBIO) Annual Breast Cancer Update: Highlights of the National Meetings Case CCC Scientific Retreat 2009 **For more information on these symposiums, please contact Christine Rhoads. |
CANCER BIOLOGY COURSESEnrollment is currently open for the following Cancer Biology courses: David Danielpour, PhD will be teaching Basic Cancer Biology and the Interface with Clinical Oncology: PHRM 520/ PATH 520, a graduate-level introductory course in cancer biology taught through the Departments of Pharmacology and Pathology. This course will give students a broad overview of current basic cancer biology, highlight recent advances in cancer therapeutics, and provide a clinical perspective of the pathogenesis and treatment of common cancers. Drs. Danielpour and Joseph Bokar, MD, PhD will be teaching Clinical Interface to Cancer Biology Conference PHRM521/ PATH521, a conference-based enrichment course of PHRM 520/PATH520, taken concurrently with PHRM520/ PATH520 or the following Spring Semester. Details can be found at: CALL FOR PAPERS– Ohio Collaborative Conference on Bioinformatics (OCCBIO)The 4th Annual Ohio Collaborative Conference on Bioinformatics (OCCBIO 2009) will be held at CWRU June 15-17, 2009. The conference provides an interdisciplinary forum for the discussion of methods, research findings, and experiences in the area of Bioinformatics and Computational Biology. An important goal of the conference is to foster long-term collaborative relationships and networking opportunities within the domain of computational approaches to biology that benefit Ohio. OCCBIO invites researchers in the broad area of bioinformatics to submit their unpublished work to the conference. The conference proceedings will be indexed. Papers will be accepted through January 27. For details, please click here. FUNDING OPPORTUNITY– James S. McDonnell FoundationThe Foundation offers Collaborative Activity Awards to initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems. In each case the focus of the collaborative activity must meet the program guidelines for one of the following program areas: Applications are continuously accepted for these awards. For more information, please click here. MARK YOUR CALENDARS–2nd Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen ScienceMarch 16–18, 2009 Human biospecimens are the foundation of the translational research that will transform patient care. The 2009 BRN Symposium: Advancing Cancer Research Through Biospecimen Science will focus on the significant impact of pre-analytical biospecimen variables on cancer research and molecular medicine. This promises to be a stimulating and informative three-day event that will feature interactive discussions and presentations about biospecimen quality and recent advances in biospecimen science. Abstract Submission Deadline: February 9 For more information, please click here. |
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIESGoldhirsh Foundation Brain Tumor Research Awards Program |
NIH Bulletin – Notices and Funding OpportunitiesExploratory Grants for Behavioral Research in Cancer Control (R21) (PA-06-351) |
|
| Produced by: Gillian Irwin 11100 Euclid Avenue, Wearn 152 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu Janice Hassinger 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-1862 phone 216-844-7832 fax janice.hassinger@uhhospitals.org |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
| If you have trouble viewing this page, click here to view the newsletter online on our website. | |